Oksana Krasnykh has been in the pharmaceutical business for about 20 years, and for over 13 of them she held management positions in Russian and foreign companies such as UNIPHARM, Pharmstandard, Materia Medica Holding, Petrovax Pharm and others. Oksana has extensive experience in marketing and sales management, as well as in successful development of business processes and implementation of big projects in the pharma market. She is well-known in the professional community and has shown herself as a vivid speaker at industry conferences and forums.
Oksana graduated from the Sechenov Moscow Medical Academy and the Moscow Institute of Physics and Technology. She has an MBA in Strategic Management and Entrepreneurship.
In 2023 Oksana was ranked among the Top 100 Commercial Directorswas listed in the TOP-1000 Russian Managers rating released annually by the Managers Association of Russia and Kommersant Publishing House.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Ministry of Health proposes to sell only proven effective dietary supplements
11 September 2024
Gene therapy trial facilitates major vision improvement
11 September 2024
Eight radiopharmaceuticals registered in Russia since 2023
10 September 2024
First-in-class combination therapy authorised for endometriosis
10 September 2024
Нажимая на кнопку «Отправить», вы даёте согласие на обработку персональных данных. Подробнее в — разделе «Политика конфиденциальности»